Fmoc-Cys(Me)-OH

Fmoc-Cys(Me)-OH is an N-Fmoc protected cysteine derivative bearing a methyl-substituted side chain (Cys(Me)) with a free carboxylic acid and an Fmoc-protected α-amino group, establishing a chiral amino acid framework suitable for stereochemically defined peptide assembly. The molecule contains a thioether functionality in the side chain rather than a free thiol, which modulates nucleophilicity and reduces disulfide scrambling during peptide coupling and subsequent handling. The carboxylic acid supports standard amide bond formation chemistry, while the Fmoc group enables base-mediated removal under peptide synthesis conditions. The combination of a protected amine, an activated carboxyl terminus, and a thioether side chain makes Fmoc-Cys(Me)-OH a practical chiral building block and derivatization intermediate for sulfur-containing peptide analogs and downstream functional materials.

1. Peptide Synthesis

Fmoc-Cys(Me)-OH is applied in solid-phase peptide synthesis and peptide building block preparation where an Fmoc-protected amino acid is required for controlled N-terminal deprotection and coupling. The α-amino group is masked by the Fmoc carbamate, while the free carboxylic acid participates in peptide coupling to form amide linkages with standard coupling reagents. The thioether side chain can be carried through synthesis without the instability associated with unprotected cysteine thiols, supporting consistent incorporation of sulfur-containing residues into longer sequences. Resulting peptide products can be used as reference standards, mechanistic probes, or scaffold components for further side-chain derivatization and analog generation in amino acid chemistry workflows.

2. Side-Chain Functionalization

Fmoc-Cys(Me)-OH is utilized for side-chain functionalization strategies targeting sulfur-containing functionality in peptidomimetics and chemical biology probes. The methylated thioether provides a defined sulfur handle that can undergo oxidation to sulfoxide or sulfone motifs, enabling controlled polarity and stereochemical effects at sulfur in downstream analogs. The Fmoc-protected backbone supports orthogonal transformations by allowing selective deprotection of the N-terminus during peptide assembly, followed by post-synthetic modification of the sulfur functionality. Downstream derivatives can serve as chemically stable cysteine surrogates for structure-activity relationship studies, enzyme interaction mapping, and molecular recognition optimization where thiol reactivity would otherwise complicate analysis.

3. Chemical Biology Probes

Fmoc-Cys(Me)-OH is employed in chemical biology research for constructing peptide and peptidomimetic ligands that probe protein binding interfaces involving sulfur-tolerant residue analogs. The presence of a stereogenic α-carbon and a thioether side chain supports incorporation into defined molecular architectures with predictable conformational and electronic characteristics. The Fmoc protection strategy enables sequential assembly of labeled or functionalized peptides, while the carboxyl terminus supports conjugation-ready peptide fragments after N-deprotection. Resulting constructs can be applied as biochemical research intermediates for affinity reagents, competition assays, and mechanistic studies requiring controlled residue identity without thiol-mediated side reactions.

4. Peptidomimetics And SAR

Fmoc-Cys(Me)-OH is suitable for peptidomimetic construction and structure-activity relationship (SAR) studies where cysteine analogs with reduced thiol reactivity are needed to tune stability and binding properties. The thioether side chain can mimic aspects of cysteine-containing motifs while offering different oxidation states and reduced propensity for disulfide exchange, supporting reproducible comparisons across analog series. The Fmoc-protected amino acid format supports systematic variation at the residue level during peptide analog synthesis, including incorporation into constrained scaffolds and fragment-based libraries. Downstream sulfur-oxidized or derivatized analogs can be generated for SAR mapping, fragment optimization, and mechanistic interpretation in applied peptide science and synthetic methodology development.

5. Pharmaceutical Intermediate Preparation

Fmoc-Cys(Me)-OH is relevant to pharmaceutical intermediate preparation and process-oriented fine chemical synthesis where protected amino acid building blocks are required for scalable peptide and peptidomimetic manufacture. The Fmoc group provides a well-established orthogonal protection scheme for N-terminal handling, while the free carboxylic acid supports conversion to activated intermediates for controlled amide bond formation. The methylated thioether side chain can reduce process complications associated with thiol oxidation and disulfide formation during manufacturing-scale operations and intermediate storage. Resulting peptide fragments and sulfur-functionalized intermediates can be carried into downstream synthetic routes for drug discovery chemistry programs, analytical reference materials, and specialty chemical production requiring defined chiral amino acid incorporation.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active